Symptomatic cerebrospinal fluid escape.

Area of Science:

• Neuroscience
• Infectious Diseases
• Virology

Background:

• Cerebrospinal fluid (CSF) viral escape is defined by detectable HIV-RNA in CSF despite undetectable plasma levels during combination antiretroviral therapy (cART).
• This condition can manifest as symptomatic CSF escape, characterized by neurological problems like cognitive decline and focal signs.
• Brain MRI may reveal white matter hyperintensities, resembling historical HIV encephalopathy presentations.

Purpose of the Study:

• To define and explore the characteristics and pathogenesis of CSF viral escape.
• To understand the role of inflammation and CNS HIV reservoirs in symptomatic escape.
• To highlight the importance of cART optimization in managing this condition.

Main Methods:

• Analysis of CSF and plasma HIV-RNA levels in patients on cART.
• Clinical assessment for neurological symptoms and signs.
• Brain Magnetic Resonance Imaging (MRI) for detecting white matter changes.
• Evaluation of CD4 cell counts and CSF pleocytosis.
• Review of potential contributing factors like adherence, drug resistance, and cART efficacy in the CNS.

Main Results:

• Symptomatic CSF escape can occur with high CD4 counts and low systemic viral load.
• Brain MRI findings often show diffuse white matter hyperintensities.
• CSF pleocytosis and CD8 T-cell brain infiltrates suggest inflammation plays a key role.
• Low nadir CD4 counts are common, indicating potential establishment of CNS HIV reservoirs.
• CSF escape is linked to factors reducing cART potency, such as poor adherence or CNS-ineffective regimens.

Conclusions:

• CSF viral escape is an inflammatory condition potentially involving reactivation of CNS HIV infection.
• Optimizing cART is crucial for reversing escape and associated neurological disease.
• Understanding CSF escape mechanisms is vital for managing HIV in the central nervous system.